PTCT
Price
$49.84
Change
+$0.29 (+0.59%)
Updated
Jun 27 closing price
Capitalization
3.95B
31 days until earnings call
RXRX
Price
$5.03
Change
-$0.37 (-6.85%)
Updated
Jun 27 closing price
Capitalization
2.04B
43 days until earnings call
Interact to see
Advertisement

PTCT vs RXRX

Header iconPTCT vs RXRX Comparison
Open Charts PTCT vs RXRXBanner chart's image
PTC Therapeutics
Price$49.84
Change+$0.29 (+0.59%)
Volume$1.39M
Capitalization3.95B
Recursion Pharmaceuticals
Price$5.03
Change-$0.37 (-6.85%)
Volume$46.63M
Capitalization2.04B
PTCT vs RXRX Comparison Chart in %
Loading...
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTCT vs. RXRX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTCT is a Buy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (PTCT: $49.84 vs. RXRX: $5.03)
Brand notoriety: PTCT and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTCT: 108% vs. RXRX: 190%
Market capitalization -- PTCT: $3.95B vs. RXRX: $2.04B
PTCT [@Biotechnology] is valued at $3.95B. RXRX’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTCT’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • PTCT’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, PTCT is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTCT’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PTCT’s TA Score: 6 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PTCT is a better buy in the short-term than RXRX.

Price Growth

PTCT (@Biotechnology) experienced а -0.72% price change this week, while RXRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

PTCT is expected to report earnings on Jul 31, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCT($3.95B) has a higher market cap than RXRX($2.05B). PTCT YTD gains are higher at: 10.412 vs. RXRX (-25.592). PTCT has higher annual earnings (EBITDA): 839M vs. RXRX (-524.77M). PTCT has more cash in the bank: 2.03B vs. RXRX (500M). RXRX has less debt than PTCT: RXRX (92.9M) vs PTCT (390M). PTCT has higher revenues than RXRX: PTCT (1.77B) vs RXRX (59.8M).
PTCTRXRXPTCT / RXRX
Capitalization3.95B2.05B193%
EBITDA839M-524.77M-160%
Gain YTD10.412-25.592-41%
P/E Ratio7.66N/A-
Revenue1.77B59.8M2,965%
Total Cash2.03B500M405%
Total Debt390M92.9M420%
FUNDAMENTALS RATINGS
PTCT: Fundamental Ratings
PTCT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTCTRXRX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
81%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTDSX16.020.08
+0.50%
Russell Inv Multifactor US Equity S
GSPQX17.500.08
+0.44%
Goldman Sachs US Eq Div and Premium C
VGSNX19.420.06
+0.31%
Vanguard Real Estate Index Institutional
DBMAX28.560.05
+0.18%
BNY Mellon Sm/Md Cp Gr A
STCEX4.61-0.01
-0.22%
Virtus Ceredex Small-Cap Value Eq C

PTCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with RXRX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
+0.59%
RXRX - PTCT
44%
Loosely correlated
-6.85%
SYRE - PTCT
44%
Loosely correlated
-4.99%
XNCR - PTCT
42%
Loosely correlated
-3.10%
BEAM - PTCT
42%
Loosely correlated
-1.98%
IDYA - PTCT
42%
Loosely correlated
-4.13%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-6.85%
CRSP - RXRX
72%
Closely correlated
N/A
BEAM - RXRX
64%
Loosely correlated
-1.98%
ABSI - RXRX
62%
Loosely correlated
-3.32%
ABCL - RXRX
59%
Loosely correlated
-3.48%
PRME - RXRX
57%
Loosely correlated
-8.68%
More